Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 0.31 0.49% 0.00
MRNS closed up 0.49 percent on Wednesday, November 20, 2024, on 22 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Boomer Sell Setup Bearish Swing Setup 0.49%
NR7 Range Contraction 0.49%
Narrow Range Bar Range Contraction 0.49%
Inside Day Range Contraction 0.49%
Wide Bands Range Expansion 0.49%
Oversold Stochastic Weakness 0.49%
Narrow Range Bar Range Contraction 0.32%
Inside Day Range Contraction 0.32%

   Recent Intraday Alerts

Alert Time
Down 3% about 17 hours ago
Boomer Sell Entry about 17 hours ago
Fell Below Previous Day's Low about 17 hours ago
Down 2 % about 17 hours ago
Possible NR7 about 17 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Alcohol Neuroscience Ketones Seizure Sedatives Fragile X Syndrome Pregnanes Neurosteroids

Is MRNS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.26
52 Week Low 0.2603
Average Volume 3,074,917
200-Day Moving Average 3.11
50-Day Moving Average 1.15
20-Day Moving Average 0.33
10-Day Moving Average 0.32
Average True Range 0.08
RSI (14) 25.93
ADX 52.82
+DI 11.72
-DI 42.68
Chandelier Exit (Long, 3 ATRs) 1.60
Chandelier Exit (Short, 3 ATRs) 0.50
Upper Bollinger Bands 0.38
Lower Bollinger Band 0.27
Percent B (%b) 0.34
BandWidth 34.38
MACD Line -0.25
MACD Signal Line -0.29
MACD Histogram 0.0374
Fundamentals Value
Market Cap 16.86 Million
Num Shares 54.6 Million
EPS -2.78
Price-to-Earnings (P/E) Ratio -0.11
Price-to-Sales 17.71
Price-to-Book 10.10
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.34
Resistance 3 (R3) 0.34 0.33 0.33
Resistance 2 (R2) 0.33 0.32 0.33 0.33
Resistance 1 (R1) 0.32 0.32 0.31 0.32 0.33
Pivot Point 0.31 0.31 0.31 0.31 0.31
Support 1 (S1) 0.30 0.30 0.29 0.30 0.29
Support 2 (S2) 0.29 0.30 0.29 0.29
Support 3 (S3) 0.28 0.29 0.28
Support 4 (S4) 0.28